Ghent University Academic Bibliography

Journal Article
A1
open access

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity : a Swedish national register-based cohort study

Cheïma Amrouch (UGent) , Davide Liborio Vetrano, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Maxim Grymonprez (UGent) , Marco Proietti, Gregory Lip, Søren Johnsen, Jonas Wastesson, et al.

(2024) FRONTIERS IN PHARMACOLOGY. 15.

Add to list

Journal Article
A1
open access

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Maxim Grymonprez (UGent) , Tine De Backer (UGent) , Xander Bertels (UGent) , Stephane Steurbaut and Lies Lahousse (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

Koen Deserranno (UGent) , Laurentijn Tilleman (UGent) , Kaat Rubben (UGent) , Dieter Deforce (UGent) and Filip Van Nieuwerburgh (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Parasitic infections related to anti-type 2 immunity monoclonal antibodies : a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)

Victor Pera, Guy Brusselle (UGent) , Sebastian Riemann (UGent) , Jan A. Kors, Erik M. Van Mulligen, Rowan Parry, Marcel de Wilde, Peter R. Rijnbeek and Katia Verhamme (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Berberine-microbiota interplay : orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites

Tessa Dehau (UGent) , Marc Cherlet (UGent) , Siska Croubels (UGent) , Michiel Van de Vliet (UGent) , Evy Goossens (UGent) and Filip Van Immerseel (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Bacterial responses to plant antimicrobials : the case of alkannin and shikonin derivatives

Angélique Rat (UGent) , Antigoni E. Koletti, Nebojsa Rodic, Vassilios P. Papageorgiou, Anne Willems (UGent) and Andreana N. Assimopoulou

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

Nayra Cristina Herreira do Valle (UGent) , Simone Janssen (UGent) , Marcus C. M. Stroet, Sofie Pollenus, Sonja Van den Block, Nick Devoogdt, Jens Debacker (UGent) , Sophie Hernot and Hilde De Rooster (UGent)

(2023) FRONTIERS IN PHARMACOLOGY. 14.

Add to list

Journal Article
A1
open access

The modulation of Chaihu Shugan Formula on microbiota composition in the simulator of the human intestinal microbial ecosystem technology platform and its influence on gut barrier and intestinal immunity in Caco-2/THP1-blue (TM) cell co-culture model

Ling Liu, Yi Lu, Chao Xu, Haitao Chen, Xuanying Wang, Yijie Wang, Biyu Cai, Bing Li, Lynn Verstrepen, Jonas Ghyselinck, et al.

(2022) FRONTIERS IN PHARMACOLOGY. 13.

Add to list

Journal Article
A1
open access

Effect of acid suppressants on non-helicobacter pylori helicobacters within parietal cells

Masahiko Nakamura, Futa Murasato, Anders Overby, Yosuke Kodama, Hirofumi Michimae, Kazuki Sasaki, Bram Flahou (UGent) , Freddy Haesebrouck (UGent) , Somay Y. Murayama, Shinichi Takahashi, et al.

(2022) FRONTIERS IN PHARMACOLOGY. 13.

Add to list

Journal Article
A1
open access

Hepatic cytochrome P450 abundance and activity in the developing and adult Gottingen Minipig : Pivotal data for PBPK modeling

Laura Buyssens, Laura De Clerck (UGent) , Wim Schelstraete, Maarten Dhaenens (UGent) , Dieter Deforce (UGent) , Miriam Ayuso, Chris Van Ginneken and Steven Van Cruchten

(2021) FRONTIERS IN PHARMACOLOGY. 12.

Academic Bibliography

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity : a Swedish national register-based cohort study

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study

Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

Parasitic infections related to anti-type 2 immunity monoclonal antibodies : a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)

Berberine-microbiota interplay : orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites

Bacterial responses to plant antimicrobials : the case of alkannin and shikonin derivatives

Safety assessment of fluorescently labeled anti-EGFR Nanobodies in healthy dogs

The modulation of Chaihu Shugan Formula on microbiota composition in the simulator of the human intestinal microbial ecosystem technology platform and its influence on gut barrier and intestinal immunity in Caco-2/THP1-blue (TM) cell co-culture model

Effect of acid suppressants on non-helicobacter pylori helicobacters within parietal cells

Hepatic cytochrome P450 abundance and activity in the developing and adult Gottingen Minipig : Pivotal data for PBPK modeling

Contents

Support

Contact